During the past decade, Magna Center for Family Medicine conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 4 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Magna Center for Family Medicine" #1 collaborator was "Bristol-Myers Squibb" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Magna Center for Family Medicine" are "Type 2 Diabetes" (4 trials), "Diabetes Mellitus" (1 trials), "Diabetes, Type 1" (1 trials), "Diabetes, Type 2" (1 trials) and "Type 1 Diabetes" (1 trials). Many other conditions were trialed in "Magna Center for Family Medicine" in a lesser frequency.

Most popular intervention types in "Magna Center for Family Medicine" are "Drug" (6 trials). Other intervention types were less common.

The name of intervention was led by "Dapagliflozin" (2 trials), "Technosphere® Insulin Inhalation Powder" (2 trials), "Comparator" (1 trials), "Insulin Aspart" (1 trials) and "Insulin Glargine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Magna Center for Family Medicine" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Magna Center for Family Medicine". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Magna Center for Family Medicine, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Magna Center for Family Medicine, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".